Cargando…
Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation
Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset o...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609353/ https://www.ncbi.nlm.nih.gov/pubmed/26504794 http://dx.doi.org/10.1155/2015/259843 |
_version_ | 1782395794960154624 |
---|---|
author | Rewiuk, Krzysztof Grodzicki, Tomasz |
author_facet | Rewiuk, Krzysztof Grodzicki, Tomasz |
author_sort | Rewiuk, Krzysztof |
collection | PubMed |
description | Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset of AF. Methods and Results. We included 60 patients with acute onset of AF, candidates for pharmacological cardioversion. The presence of cardiovascular comorbidities was connected with higher concentration of OPG and lower level of TRAIL right from the first hours of AF paroxysm. The initial TRAIL level correlated also positively with left ventricle ejection fraction and negatively with left atrium diameter. We found subsequent increase of OPG in subgroups selected on the basis of CHA(2)DS(2)-VASc scoring. Although basal concentrations of studied markers did not allow prediction of the restoration of sinus rhythm, we observed important increase of TRAIL concentration in subgroup with sinus rhythm maintenance (94.11 ± 29.46 versus 111.39 ± 30.23 pg/mL; p = 0.002). Conclusions. OPG and TRAIL are associated with the underlying cardiovascular damage in AF, but their balance is modulated by the fact of sinus rhythm restoration. Determining the suitability of OPG and TRAIL as predictive markers in AF requires further prospective studies. |
format | Online Article Text |
id | pubmed-4609353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46093532015-10-26 Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation Rewiuk, Krzysztof Grodzicki, Tomasz Biomed Res Int Research Article Background. There is a growing amount of evidence that inflammatory processes are involved in the development of atrial fibrillation (AF) and its complications. We decided to investigate the behavior of osteoprotegerin (OPG) and TNF-related apoptosis inducing ligand (TRAIL) in terms of acute onset of AF. Methods and Results. We included 60 patients with acute onset of AF, candidates for pharmacological cardioversion. The presence of cardiovascular comorbidities was connected with higher concentration of OPG and lower level of TRAIL right from the first hours of AF paroxysm. The initial TRAIL level correlated also positively with left ventricle ejection fraction and negatively with left atrium diameter. We found subsequent increase of OPG in subgroups selected on the basis of CHA(2)DS(2)-VASc scoring. Although basal concentrations of studied markers did not allow prediction of the restoration of sinus rhythm, we observed important increase of TRAIL concentration in subgroup with sinus rhythm maintenance (94.11 ± 29.46 versus 111.39 ± 30.23 pg/mL; p = 0.002). Conclusions. OPG and TRAIL are associated with the underlying cardiovascular damage in AF, but their balance is modulated by the fact of sinus rhythm restoration. Determining the suitability of OPG and TRAIL as predictive markers in AF requires further prospective studies. Hindawi Publishing Corporation 2015 2015-10-04 /pmc/articles/PMC4609353/ /pubmed/26504794 http://dx.doi.org/10.1155/2015/259843 Text en Copyright © 2015 K. Rewiuk and T. Grodzicki. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Rewiuk, Krzysztof Grodzicki, Tomasz Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation |
title | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation |
title_full | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation |
title_fullStr | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation |
title_full_unstemmed | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation |
title_short | Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation |
title_sort | osteoprotegerin and trail in acute onset of atrial fibrillation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609353/ https://www.ncbi.nlm.nih.gov/pubmed/26504794 http://dx.doi.org/10.1155/2015/259843 |
work_keys_str_mv | AT rewiukkrzysztof osteoprotegerinandtrailinacuteonsetofatrialfibrillation AT grodzickitomasz osteoprotegerinandtrailinacuteonsetofatrialfibrillation |